(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-iodobenzyl)pyrrolidine-2-carboxylic acid, 97%, 250mg

4-Hydroxybenzoic acid, min. 98%, for synthesis, 100 g, plastic packaging.

4-Bromo-2,6-diaminopyridine, 98.0%, 5g

5-Fluoro-2-hydroxypyridine, 99.00%, 25g

4-(1H-Imidazol-4-yl)benzoic Acid, 95.0%, 250mg

N,N-Diisopropylethylamine (DIPEA), 250mL, >=99.5%, for peptide synthesis, glass packaging

1-Bromomethyl-cyclopropanecarbonitrile, 95.0%, 1g

6-Bromo-7-methoxyquinazolin-4(1H)-one, 98%, 100mg

1-(2-Pyridin-2-yl-ethyl)piperazine, 97.0%, 1g

ethyl 5-{[1,1'-biphenyl]-4-yl}-1H-pyrazole-3-carboxylate, 95.0%, 2g

tert-Butyl 2-oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate, 97%, 250mg

4-Bromofluorobenzene>98.0%(GC)25g

2-Methylbutyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate, 95.0%, 1g